Comparison of pancreatitis-preventing effects between pancreatic duct stents with different lengths

Comparison of pancreatitis-preventing effects between pancreatic duct stents with different lengths - pancreatitis-preventing effects of stents with different lengths

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008290

Enrollment

150

Registered

2012-07-01

Start date

2012-06-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic or biliary disorders needing ERCP

Interventions

3cm-pancreatic stent 5cm-pancreatic stent

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases undergoing ERCP who have either 1.history of post-ERCP pancreatitis, 2.difficulty in bile duct cannulation, 3.use of pancreatic duct guide wire, 4.papillary dilatation or EST, 5.invasive treatment against pancreas

Exclusion criteria

Exclusion criteria: failure to obtain written informed consent

Design outcomes

Primary

Measure	Time frame
occurrence rate of post-ERCP pancreatitis	—

Countries

Japan

Contacts

Public ContactNobuyuki Matsuhashi

NTT Medical Center Tokyo Department of Gastroenterology

nmatuha-tky@umin.ac.jp81334486245

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026